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rheumatic heart disease showed significant reduction in
value of EF while those with ischemic heart disease
showed constant means of EF value even they show pro-
gressive increase in their readings on period of follow up,
the means of EF for all pattern of heart disease on one
week, one month & on three months (51.7%, 53.26%,
56.34%) respectively. There were many parameter stud-
ied to find its burden on systolic function (HTN, DM,
Smoking & kat chewing) but the study revealed that all
of which have effect on EF value but the most important
& that which had significant effect is LVEDD pre opera-
tively, the EF showed reduction post operatively as the
LVEDD is big before surgical intervention.
Conclusion: There is reduction in cardiac systolic
function when it is evaluated after open cardiac surgery
but this reduction seen to be improve after weeks of
operation, so immediate evaluation not reliable in assess-
ment of outcome of cardiac surgery & assessment of left
ventricular functions, considering all surgical & para-sur-
gical effects on left ventricular function.
http://dx.doi:10.1016/j.jsha.2013.03.143
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Background/Hypothesis: The advent of technology
has made it safe to implant pacemakers (PM) in children.
However, safety of neonatal PM implantation is unclear.
We aim to report our experience with neonatal PM
implantation in regard to visibility and long-term
outcome.
Methods: We performed a retrospective analysis of
patients (PTS) who underwent PM implantation during
the first month of life at our institution. The data
obtained: demographics, diagnoses, indications for pac-
ing, follow-up, and PM revisions.
Results: Between April-1988 and May-2011, Twenty-
nine neonates (15 males) underwent PM implantation,
median age 14 days (range 2–30) weight 3.1 Kg (range
2–4.5). The indications for pacing were: surgical AV block
(12), congenital AV block in (16), and Long QT syndrome
(1). All PM’s were epicardial single chamber system with
abdominal pocket and VVI mode. The median pacing
threshold at implant was 0.8 V at 0.5 ms (range 0.5–1.7).
There were no PM infections, wound dehiscence or PM
related mortality; however there were three deaths after
palliation for complex congenital heart disease. The PTS
were followed for 7 years (1–24) during which 15 revi-
sions were done for 13 patients. The initial revision was
needed after median of 5 years (4–9) for battery depletion
(10), upgrade (2), and lead malfunction (1). One PTS
developed cardiomyopathy after 3.5 years of pacing and
improved with cardiac resynchronization.
Conclusion: Pacemakers are a safe in neonates
including low birth weight.
Pacemaker related morbidity and mortality are rare
however longer follow up is need to assess the effect of
pacing on ventricular function.
http://dx.doi:10.1016/j.jsha.2013.03.144
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Dilated cardiomyopathy is an important cause of con-
gestive cardiac failure in infants and children. Mobilizing
hematopoietic progenitor cells is a promising interven-
tion to this deadly disease. Aim of the work: to evaluate
the granulocyte colony stimulating factor (GCSF) as a
therapeutic modality in children with idiopathic dilated
cardiomyopathy (IDCM). subjects and methods: This
case control prospective study was conducted on 20 chil-
dren with IDCM following up at cardiology clinic Chil-
dren’s Hospital, Ain shams university (group 1) who
were compared to another ten age, sex, duration of illness
and systolic function matched children with IDCM as a
control group (group 2). They were subjected to history
taking, clinical Examination, echocardiographic study of
the left ventricle and cluster of differentiation thirty four
T (CD34+) cells assessment in peripheral blood before
and one week after granulocyte colony stimulating factor
intake for five consecutive days by group1. GCSF was not
given to group 2. Results: a significant improvement in
echocardiographic data and increase of the CD34+T cells
was found in group 1 patients post granulocyte colony
stimulating factor intake one week after GCSF intake
and for the next 6 months but not in group 2. The per-
centage of change of the CD34+T cells showed no signif-
icant correlation with the percentage of change of the left
ventricular dimensions and systolic function.
Conclusion: Administration of GCSF to children
with IDCM resulted in clinical and echocardiographic
improvement that was not correlated to the mobilized
cluster of differentiation thirty four T cells, implying the
involvement of additional mechanisms than simple stem
cell mobilization.
http://dx.doi:10.1016/j.jsha.2013.03.145
S-100 B protein and perioperative brain injury in
infants and children undergoing open heart surgery
using cardiopulmonary bypass
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